non-small cell lung cancer

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:cancer gptkb:disease
gptkbp:accountsFor	about 85% of lung cancer cases
gptkbp:affects	gptkb:cancer
gptkbp:diagnosedBy	gptkb:CT_scan imaging PET scan biopsy
gptkbp:guidanceSystem	gptkb:NCCN_Guidelines gptkb:ASCO_Guidelines
gptkbp:hasBiomarker	gptkb:ALK_rearrangement gptkb:EGFR_mutation gptkb:KRAS_mutation gptkb:PD-L1_expression
gptkbp:hasMetastasisSite	gptkb:bone gptkb:adrenal_gland brain liver
gptkbp:hasScreening	gptkb:low-dose_CT_scan
gptkbp:hasSurvivalRate	5-year survival rate varies by stage
gptkbp:ICD-10_code	C34
gptkbp:incidence	more common in men higher in older adults increasing in women
gptkbp:prevalence	most common type of lung cancer
gptkbp:prevention	smoking cessation avoiding carcinogen exposure
gptkbp:prognosis	variable
gptkbp:riskFactor	gptkb:air_pollution smoking exposure to asbestos exposure to radon gas
gptkbp:stageName	stage I stage II stage III stage IV
gptkbp:subspecies	gptkb:cancer gptkb:large_cell_carcinoma
gptkbp:symptom	fatigue weight loss cough shortness of breath chest pain
gptkbp:treatment	gptkb:radiation_therapy gptkb:immunotherapy gptkb:targeted_therapy surgery chemotherapy
gptkbp:bfsParent	gptkb:ALK gptkb:Alimta gptkb:EGFR_signaling_pathway gptkb:MEK_inhibitors gptkb:NP_005334.1 gptkb:RAF_inhibitors gptkb:adagrasib gptkb:dabrafenib gptkb:sotorasib gptkb:Avastin
gptkbp:bfsLayer	6
https://www.w3.org/2000/01/rdf-schema#label	non-small cell lung cancer